← SynDRA
LY-2874455
SynDRA canonical compound SYN0038570 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | FGFR1 | FGFR2 | FGFR3 | FGFR4 | KDR |
| Mechanism of action | FGFR antagonist |
All known targets
- FGFR2
- FGFR1
- FGFR3
- FGFR4
- KDR
Mechanisms of action (all sources)
- FGFR3 INHIBITOR
- Fibroblast growth factor receptor inhibitor
- FGFR1 INHIBITOR
- FGFR4 INHIBITOR
- FGFR2 INHIBITOR
- FGFR antagonist
- FGFR2 MODULATOR
Cross-references
Synonyms
- LY2874455
- LY 2874455
- UNII-E9M363811V
- CHEMBL3828009
- E9M363811V
- AK186860
- (R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)-ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
- C21H19Cl2N5O2
- (R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
- GKJCVYLDJWTWQU-CXLRFSCWSA-N
- SCHEMBL298446
- SCHEMBL298445
- QCR-90
- GTPL8104
- DTXSID20154776
- MolPort-044-724-281
- MolPort-023-219-117
- EX-A1340
- BCP04756
- ZINC73069242
- BDBM50189781
- 2529AH
- s7057
- AKOS027251051
- 1H-Pyrazole-1-ethanol, 4-((1E)-2-(5-((1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy)-1H-indazol-3-yl)ethenyl)-
- 2-[4-[(E)-2-[5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-1H-indazol-3-yl]ethenyl]pyrazol-1-yl]ethanol
- (R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol.
- LY2874455 monohydrate
- NSC771750
- NSC783670
- BCP9000878
- CCG-269169
- CS-0907
- DB13022
- LM 1476
- NSC-771750
- NSC-783670
- (R)-(E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
- (R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethan-1-ol
Look up LY-2874455 in the interactive SynDRA portal →